FOLH1 and posterior cortical atrophy: Therefore, the diagnosis of targeted PSMA can be applied in conditions with low androgen activity, such as castration-resistant PCa (CRPC) (32–34).Therefore, PSMA can be used as a targeted and specific marker in the targeted diagnosis and treatment of PCa (35, 36).